
| 2018 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2016 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2012 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 2
Sole participant: 1
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2018 | 50.000 | 0 | 50.000 | 1 | ||
| 2016 | 0 | 4.369.293 | 311.596 | 1 | ||
| 2012 | 0 | 2.482.306 | 644.531 | 1 | ||
Total number of partners: 15
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 15
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2018-05-01 | TETHIS-SBS-CTC: An innovative diagnostic testing platform to identify and characterize circulating tumour cells (CTCs) in blood samples. | TETHIS-SBS-CTC | coordinator | 50.000 | 1 |
| 2016-06-01 | Towards Replacement of Critical Catalyst Materials by Improved Nanoparticle Control and Rational Design | CritCat | participant | 4.369.293 | 11 |
| 2012-01-01 | Biomarker Applications for Nanotechnology and Imaging in Diabetes | UroSense | participant | 2.482.306 | 6 |